EnWave Corporation
TSX VENTURE : ENW
FRANKFURT : E4U

EnWave Corporation

March 08, 2012 09:00 ET

EnWave Chairman Wins LifeSciences B.C. Innovation & Achievement Award

VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 8, 2012) - EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") today announced that LifeSciences British Columbia ("LSBC") has awarded Dr. Timothy Durance, Chairman and Co-CEO of EnWave, with the 2012 Innovation & Achievement Award for his development of EnWave's Radiant Energy Vacuum ("REV") technology.

This award is presented annually by LSBC to recognize individuals and organizations that have made outstanding contributions to the development of British Columbia's life sciences industry across all sub-sectors, from biopharmaceuticals and medical devices to bioproducts and bioenergy - sectors which are critical to the economic future of the province and country.

"This year's award winners are outstanding," stated Don Enns, President of LifeSciences BC. "British Columbia has some great leaders in biotech, and the four individuals and one company selected for these awards are incredible innovators. Our sector is world-class, and these winners represent significant achievements resulting in economic growth for B.C."

"Over the past year, we have made significant technological advancements in relation to the efficient dehydration of biopharmaceuticals," stated Dr. Durance. "I am sincerely humbled by this noteworthy recognition. The innovation and achievement that EnWave has accomplished thus far in the life sciences space is very encouraging."

The LifeSciences British Columbia Awards will be presented at a gala ceremony the evening of Thursday, April 19th, 2012, in front of an audience of approximately 600 guests representing the biopharmaceutical, medical device, bioproducts, bioenergy and greater life sciences community at the Vancouver Convention Centre.

About LifeSciences British Columbia

LifeSciences British Columbia is a not-for-profit, non-government industry association that represents and supports the biopharmaceutical, medical device, bioproducts, bioenergy and greater life sciences community of British Columbia through facilitation of partnering and investment, advocacy, education, and promotion of our world-class science and industry. More information about LifeSciences B.C. is available at http://www.lifesciencesbc.ca/.

About EnWave

EnWave Corporation is a Vancouver-based industrial technology company developing commercial applications for its proprietary Radiant Energy Vacuum (REV) dehydration technology. In collaboration with an expanding list of multinational partners, including Nestlé, Kellogg's, Grupo Bimbo, Grimmway Farms, Ocean Spray Cranberries, Hormel, Bonduelle and Merck. EnWave is introducing REV as a new dehydration standard in the food and biological material sectors: potentially faster and cheaper than freeze drying, with better end product quality than air drying or spray drying.

EnWave currently has six REV platforms: commercial-scale nutraREV™ and MIVAP™ are used in the food industry to dry fruits, vegetables, meat, herbs and seafood quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour. The Company is also developing powderREV™ for bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes; quantaREV™ for continuous, high-volume low-temperature drying of pastes, gels, liquids, or particulates; and bioREV™ and freezeREV™ as new methods to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Dr. Tim Durance, Chairman & Co-CEO

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. There is no guarantee that the Company's REV technology can or will improve processes in the target industry; even if the Company's REV technology can be used as described in this document, there is no guarantee that such use will result in orders for the Company's REV technology. All figures comparing REV technologies to freeze drying or other dehydration technologies are provided as examples of data obtained through the Company's own scientific and testing programs; each product must be tested individually to determine the benefits of using REV.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information